4.5 Article

Endothelin-1 and Endothelin A Receptor Immunoreactivity Is Increased in Patients with Diabetic Nephropathy

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Endothelin-1 and diabetic complications: Focus on the vasculature

Adviye Ergul

PHARMACOLOGICAL RESEARCH (2011)

Article Urology & Nephrology

Avosentan for Overt Diabetic Nephropathy

Johannes F. E. Mann et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Article Endocrinology & Metabolism

Endothelin-1 levels and albuminuria in patients with type 2 diabetes mellitus

Claudete M. Zanatta et al.

DIABETES RESEARCH AND CLINICAL PRACTICE (2008)

Review Urology & Nephrology

Reversal of proteinuric renal disease and the emerging role of endothelin

Matthias Barton

NATURE CLINICAL PRACTICE NEPHROLOGY (2008)

Article Transplantation

Comprehensive immunohistological analysis of the endothelin system in human kidney grafts

K Frank et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)

Article Urology & Nephrology

Endothelin receptors in the kidney of patients with proteinuric and non-proteinuric nephropathies

Anastasios Drakopoulos et al.

RENAL FAILURE (2006)

Article Cardiac & Cardiovascular Systems

Nephroprotective effect of Bosentan in diabetic rats

A Cosenzi et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)

Article Cardiac & Cardiovascular Systems

Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat

SS Ding et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)

Article Urology & Nephrology

Diabetes mellitus increases endothelin-1 gene transcription in rat kidney

GM Hargrove et al.

KIDNEY INTERNATIONAL (2000)

Article Urology & Nephrology

Elevated endothelin-1 in tubular epithelium is associated with renal allograft rejection

C Chareandee et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2000)